Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Hārvija-Bredšova indekss× | Mayo Score kolīta čūlu slimības gadījumā× | |
|---|---|---|
| Nozare | Gastroenteroloģija | Gastroenteroloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1980 | 1987 |
| Autors≠ | R. F. Harvey and J. M. Bradshaw | Schroeder, K. W., Tremaine, W. J., and Ilstrup, D. M. |
| Tips | Clinician-rated | Clinician-rated |
| Pirmavots≠ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ | Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987). Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine, 317(26), 1625–1629. DOI ↗ |
| Citi nosaukumi≠ | HBI | Mayo Clinic Score, UC Mayo Score |
| Saistītās≠ | 5 | 4 |
| Kopsavilkums≠ | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. | The Mayo Score is a validated tool for assessing disease activity in ulcerative colitis, integrating clinical symptoms and endoscopic findings. Introduced by Schroeder and colleagues in 1987, it has become the reference standard for UC activity assessment in clinical trials and practice. The score combines stool frequency, rectal bleeding, overall physician global assessment, and endoscopic subscore into a single 0–12 scale. |
| ScholarGateDatu kopa ↗ |
|
|